Document is current

Article History

Received: 19 December 2025

Accepted: 11 June 2026

First Online: 6 July 2026

Declarations

:

: Claudia Carmassi has been a continuing medical education speaker and/or a consultant or advisor to and/or has received honoraria from Angelini, Lundbeck, Gedeon Richter, Neuraxpharm, Teva Italia and Viatris. Christoph Correll has been a consultant and/or advisor to or has received honoraria from AbbVie, Alkermes, Allergan, Angelini, Aristo, Autobahn, Boehringer Ingelheim, Bristol Meyers Squibb, Cardio Diagnostics, Cerevel, CNX Therapeutics, Compass Pathways, Darnitsa, Delpor, Denovo, Draig, Eli Lilly, Eumentis Therapeutics, Gedeon Richter, GH, Hikma, Holmusk, IntraCellular Therapies, Jamjoom Pharma, Janssen/J&J, Karuna, LB Pharma, Lundbeck, MedInCell, MedLink Global, Merck, Mindpax, Mitsubishi Tanabe Pharma, Maplight, Mylan, Neumora Therapeutics, Neuraxpharm, Neurocrine, Neurelis, Neurosterix, NeuShen, Newron, Noven, Novo Nordisk, Orion Pharma, Otsuka, PPD Biotech, Recognify Life Science, Recordati, Relmada, Response Pharmaeutical, Reviva, Rovi, Saladax, Sanofi, Seqirus, Servier, Sumitomo Pharma America, Sunovion, Sun Pharma, Supernus, Tabuk, Takeda, Teva, Terran, Tolmar, Vertex, Viatris and Xenon Pharmaceuticals. He provided expert testimony for Janssen, Lundbeck, Neurocrine and Otsuka. He served on a Data Safety Monitoring Board for Compass Pathways, IntraCellular Therapies, Relmada, Reviva and Rovi. He has received grant support from Boehringer Ingelheim, Janssen and Takeda. He received royalties from UpToDate and is also a stock option holder of Cardio Diagnostics, Kuleon Biosciences, LB Pharma, MedLink Global, Mindpax, Quantic and Terran. Javier de Diego-Adeliño has received grants from the Spanish Ministry of Health Instituto de Salud Carlos III (PI23/00469) and from the Fundació La Marató de TV3 (202207-31) and has served as an advisor or continuing medical education speaker for Neuraxpharm, Johnson & Johnson, Lundbeck, Pfizer, Esteve, Viatris and Amgen. Antonio Vian-Lains has served as an advisor or continuing medical education speaker for Neuraxpharm, Johnson & Johnson and Lundbeck. Ciro Oliveira has received honoraria from Angelini Pharma Portugal, AstraZeneca, Bial, GlaxoSmithKline, Jaba Recordati, Johnson & Johnson, Lundbeck, Neuraxpharm and Rovi SA. Vikas Mohan Sharma and Alex Schneider-Pérez are full-time employees of Neuraxpharm.

: Not applicable.

: Not applicable.

: Not applicable.

: Not applicable.

: Not applicable.

: All authors equally contributed to the development of this manuscript by reviewing the relevant literature in preparation for the advisory board meeting, participated in discussions during the meeting and contributed to the interpretation of evidence. All authors reviewed, provided critical comments on and approved the drafts of the manuscript, approved the final version for publication and agree to be accountable for the work.